市場調査レポート

商品コード

慢性疾患管理市場の2030年までの予測：タイプ別、疾患タイプ別、エンドユーザー別、地域別の世界分析

Chronic Disease Management Market Forecasts to 2030 - Global Analysis By Type, Disease Type, End User and By Geography

出版日: 2023年11月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,150 597,849円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 756,315円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 914,781円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,080,450円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、世界の慢性疾患管理市場は2023年に63億米ドルを占め、予測期間中にCAGR 13.8%で成長し、2030年には156億米ドルに達する見込みです。

慢性疾患管理市場は、糖尿病、心臓病、がんなどの長期にわたる非伝染性の健康状態に対処するヘルスケア分野です。患者の生活の質を向上させるために、これらの疾患の予防、モニタリング、治療を目的としたさまざまな戦略や技術が含まれます。その用途には、患者の遠隔モニタリング、個別化された治療計画、データ主導の介入などが含まれます。

NCBIによると、慢性疾患は死亡原因の約60％、世界の疾病負担の43％を占めています。

高齢化人口の増加

人口統計が高齢者人口へとシフトするにつれ、慢性疾患の有病率が高まっています。この人口動向は、ヘルスケアシステムとリソースに大きな負担をかけるため、疾病管理戦略の強化が必要となります。慢性疾患に対する専門的なケア、予防措置、長期的なサポートに対する需要は増加傾向にあり、ニーズに合わせたヘルスケアソリューションやテクノロジーの開発が促進されています。高齢化社会のヘルスケアニーズに対応することは、高齢者の生活の質を向上させるだけでなく、効果的かつ効率的なケアを提供する上でますます不可欠となり、慢性疾患管理市場の成長を促進します。

高度なプログラムの導入にはコストがかかる

最先端技術、遠隔モニタリングシステム、個別化された治療ソリューションの開発・導入には、多額の財政投資が必要となる場合が多いです。ヘルスケア組織や医療提供者は予算の制約を受け、高価なテクノロジーの導入にリソースを割り当てるという課題に直面することがあります。さらに、こうしたコストは患者の負担増につながり、高度な慢性疾患管理へのアクセスを制限することにもなりかねないです。また、経済的負担は、小規模ヘルスケア施設や十分なサービスを受けていない地域が包括的な疾病管理サービスを提供することを躊躇させ、健康格差を悪化させる可能性があります。効果的な慢性疾患管理ソリューションへの公平なアクセスを確保するためには、こうした費用の障壁を軽減することが不可欠です。

政府のヘルスケア政策とインセンティブ

世界の多くの政府は、慢性疾患の増加による経済的・公衆衛生的影響を認識しています。その結果、革新的な疾病管理ソリューションの開発と採用を奨励する政策を実施しています。インセンティブには、医療システムへのテクノロジーと遠隔医療の統合を促進し、プロバイダーが効果的な慢性疾患管理サービスを提供しやすくするための財政支援、償還プログラム、規制の枠組みなどが含まれます。このような政策は市場の成長を促すだけでなく、医療へのアクセスの改善、医療費の削減、患者の転帰の改善に貢献し、ヘルスケア利害関係者にとっても患者にとってもWin-Winのシナリオを生み出します。

厳しい規制とコンプライアンス要件

規制は患者の安全とデータ・セキュリティを確保するために不可欠ですが、過度に複雑で制限的な規制環境はイノベーションを阻害し、慢性疾患を管理するための新技術やソリューションの迅速な開発と展開を妨げる可能性があります。コンプライアンスの課題は、製品の市場投入にかかる時間とコストを増大させ、企業やヘルスケアプロバイダーに障壁をもたらす可能性があります。さらに、複雑な規制状況を乗り切ることは、市場参入を躊躇させ、競争を制限し、先進的な慢性疾患管理ソリューションの利用を制限する可能性があり、最終的に患者のケアとヘルスケアシステムの効率に影響を与えます。

COVID-19の影響：

COVID-19の流行は慢性疾患管理市場に大きな影響を与えました。ヘルスケアシステムがパンデミックへの対応に注力しているため、日常的な慢性疾患ケアに混乱が生じています。遠隔医療と遠隔モニタリング・ソリューションは、対面診療を最小限に抑え、脆弱な人々の被曝リスクを軽減するために注目されるようになっています。しかし、パンデミック関連の取り組みに資源が振り向けられ、日常的なスクリーニングや治療が遅れた結果、管理されていない慢性疾患が増加する可能性があり、長期的な健康への影響が懸念されます。パンデミックは、デジタルヘルスソリューションの採用を加速させるとともに、弾力的で適応性の高い慢性疾患管理戦略の必要性を浮き彫りにしています。

予測期間中、サービス分野が最大となる見込み

サービス分野は市場で有利な成長が見込まれます。同市場のサービスには、長期的な健康状態に対処する個人のニーズに対応するよう調整された、幅広いヘルスケアサービスが含まれます。これらのサービスには、疾病予防や教育、診断検査、治療計画、投薬管理、ライフスタイル・カウンセリングなどが含まれます。ヘルスケア・プロバイダーは、遠隔モニタリング、遠隔医療相談、慢性疾患を効果的に追跡・管理するためのデータ主導型介入などのテクノロジーを活用することで、患者中心のケアを提供しています。サポートグループやメンタルヘルスサービスも、慢性疾患とともに生きることの感情的・心理的側面に対処する上で重要な役割を果たしています。

糖尿病分野は予測期間中に最も高いCAGRが見込まれる

糖尿病分野は、予測期間中に最も速いCAGRの成長が見込まれます。糖尿病は、その広範な有病率と包括的な管理の必要性から、慢性疾患の中心的な焦点となっています。高い血糖値を特徴とするこの慢性疾患は、継続的なモニタリング、ライフスタイルの調整、そしてしばしば薬物療法やインスリン療法を必要とします。ヘルスケアプロバイダーやデジタルヘルスソリューションは、グルコースモニタリング機器、糖尿病教育プログラム、個人に合わせた食事・運動計画、遠隔健康相談など、さまざまなサービスを提供しています。その目的は、糖尿病患者が自分の状態をよりよく管理し、合併症のリスクを減らし、全体的な生活の質を改善できるようにすることです。

最もシェアの高い地域

予測期間中、北米市場が引き続き市場シェアの大半を占めると予想されます。この地域には米国とカナダが含まれ、高齢化、生活習慣病、慢性疾患の負担増が革新的な疾病管理ソリューションの需要を牽引しています。遠隔医療、ウェアラブルデバイス、電子カルテの採用が広がっており、遠隔モニタリングや個別ケアを可能にしています。さらに、北米では政府の政策とヘルスケア規制が慢性疾患管理プログラムの開発と実施を奨励することが多く、患者の転帰の改善と慢性疾患の経済的影響の軽減に焦点を当てたヘルスケア革新の肥沃な土壌となっています。

CAGRが最も高い地域：

予測期間中、アジア太平洋地域のCAGRが最も高いと予測されます。この地域は人口が多く、中間層が増加し、ライフスタイルが変化しているため、糖尿病、心血管疾患、呼吸器疾患などの慢性疾患の有病率が増加しています。ヘルスケアプロバイダーやテクノロジー企業は、疾病予防、モニタリング、治療のための革新的なソリューションを積極的に導入しています。遠隔医療サービス、モバイル健康アプリ、遠隔監視装置は、特に中国やインドのような国々で人気を集めています。医療アクセスを改善するための政府の取り組みや、慢性疾患の管理の重要性に関する患者の意識の高まりが、市場の拡大に寄与しています。

無料のカスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

企業プロファイル
- 追加市場プレイヤーの包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋地域
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋地域
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東とアフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東とアフリカ

第9章主な発展

契約、パートナーシップ、コラボレーション、合弁事業
買収と合併
新製品の発売
事業拡大
その他の主要戦略

第10章企業プロファイル

HealthSmart Holdings, Inc.
Vivify Health, Inc
Medecision, Inc.
Pegasystems Inc.
Allscripts Healthcare Solutions, Inc.
Altruista Health
AxisPoint Health
Epic Corporation Inc.
TriZetto Corporation
EXL Healthcare
ZeOmega Inc.
Health Catalyst

図表

List of Tables

Table 1 Global Chronic Disease Management Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Chronic Disease Management Market Outlook, By Type (2021-2030) ($MN)
Table 3 Global Chronic Disease Management Market Outlook, By Solutions (2021-2030) ($MN)
Table 4 Global Chronic Disease Management Market Outlook, By On-Premise Solution (2021-2030) ($MN)
Table 5 Global Chronic Disease Management Market Outlook, By Cloud-Based Solution (2021-2030) ($MN)
Table 6 Global Chronic Disease Management Market Outlook, By Web-Based (2021-2030) ($MN)
Table 7 Global Chronic Disease Management Market Outlook, By Services (2021-2030) ($MN)
Table 8 Global Chronic Disease Management Market Outlook, By Consulting Services (2021-2030) ($MN)
Table 9 Global Chronic Disease Management Market Outlook, By Implementation Services (2021-2030) ($MN)
Table 10 Global Chronic Disease Management Market Outlook, By Educational Services (2021-2030) ($MN)
Table 11 Global Chronic Disease Management Market Outlook, By Other Types (2021-2030) ($MN)
Table 12 Global Chronic Disease Management Market Outlook, By Disease Type (2021-2030) ($MN)
Table 13 Global Chronic Disease Management Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
Table 14 Global Chronic Disease Management Market Outlook, By Diabetes (2021-2030) ($MN)
Table 15 Global Chronic Disease Management Market Outlook, By Cancer (2021-2030) ($MN)
Table 16 Global Chronic Disease Management Market Outlook, By Asthma (2021-2030) ($MN)
Table 17 Global Chronic Disease Management Market Outlook, By Chronic Obstructive Pulmonary Disorders (2021-2030) ($MN)
Table 18 Global Chronic Disease Management Market Outlook, By Other Disease Types (2021-2030) ($MN)
Table 19 Global Chronic Disease Management Market Outlook, By End User (2021-2030) ($MN)
Table 20 Global Chronic Disease Management Market Outlook, By Healthcare Providers (2021-2030) ($MN)
Table 21 Global Chronic Disease Management Market Outlook, By Healthcare Payers (2021-2030) ($MN)
Table 22 Global Chronic Disease Management Market Outlook, By Other End Users (2021-2030) ($MN)
Table 23 North America Chronic Disease Management Market Outlook, By Country (2021-2030) ($MN)
Table 24 North America Chronic Disease Management Market Outlook, By Type (2021-2030) ($MN)
Table 25 North America Chronic Disease Management Market Outlook, By Solutions (2021-2030) ($MN)
Table 26 North America Chronic Disease Management Market Outlook, By On-Premise Solution (2021-2030) ($MN)
Table 27 North America Chronic Disease Management Market Outlook, By Cloud-Based Solution (2021-2030) ($MN)
Table 28 North America Chronic Disease Management Market Outlook, By Web-Based (2021-2030) ($MN)
Table 29 North America Chronic Disease Management Market Outlook, By Services (2021-2030) ($MN)
Table 30 North America Chronic Disease Management Market Outlook, By Consulting Services (2021-2030) ($MN)
Table 31 North America Chronic Disease Management Market Outlook, By Implementation Services (2021-2030) ($MN)
Table 32 North America Chronic Disease Management Market Outlook, By Educational Services (2021-2030) ($MN)
Table 33 North America Chronic Disease Management Market Outlook, By Other Types (2021-2030) ($MN)
Table 34 North America Chronic Disease Management Market Outlook, By Disease Type (2021-2030) ($MN)
Table 35 North America Chronic Disease Management Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
Table 36 North America Chronic Disease Management Market Outlook, By Diabetes (2021-2030) ($MN)
Table 37 North America Chronic Disease Management Market Outlook, By Cancer (2021-2030) ($MN)
Table 38 North America Chronic Disease Management Market Outlook, By Asthma (2021-2030) ($MN)
Table 39 North America Chronic Disease Management Market Outlook, By Chronic Obstructive Pulmonary Disorders (2021-2030) ($MN)
Table 40 North America Chronic Disease Management Market Outlook, By Other Disease Types (2021-2030) ($MN)
Table 41 North America Chronic Disease Management Market Outlook, By End User (2021-2030) ($MN)
Table 42 North America Chronic Disease Management Market Outlook, By Healthcare Providers (2021-2030) ($MN)
Table 43 North America Chronic Disease Management Market Outlook, By Healthcare Payers (2021-2030) ($MN)
Table 44 North America Chronic Disease Management Market Outlook, By Other End Users (2021-2030) ($MN)
Table 45 Europe Chronic Disease Management Market Outlook, By Country (2021-2030) ($MN)
Table 46 Europe Chronic Disease Management Market Outlook, By Type (2021-2030) ($MN)
Table 47 Europe Chronic Disease Management Market Outlook, By Solutions (2021-2030) ($MN)
Table 48 Europe Chronic Disease Management Market Outlook, By On-Premise Solution (2021-2030) ($MN)
Table 49 Europe Chronic Disease Management Market Outlook, By Cloud-Based Solution (2021-2030) ($MN)
Table 50 Europe Chronic Disease Management Market Outlook, By Web-Based (2021-2030) ($MN)
Table 51 Europe Chronic Disease Management Market Outlook, By Services (2021-2030) ($MN)
Table 52 Europe Chronic Disease Management Market Outlook, By Consulting Services (2021-2030) ($MN)
Table 53 Europe Chronic Disease Management Market Outlook, By Implementation Services (2021-2030) ($MN)
Table 54 Europe Chronic Disease Management Market Outlook, By Educational Services (2021-2030) ($MN)
Table 55 Europe Chronic Disease Management Market Outlook, By Other Types (2021-2030) ($MN)
Table 56 Europe Chronic Disease Management Market Outlook, By Disease Type (2021-2030) ($MN)
Table 57 Europe Chronic Disease Management Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
Table 58 Europe Chronic Disease Management Market Outlook, By Diabetes (2021-2030) ($MN)
Table 59 Europe Chronic Disease Management Market Outlook, By Cancer (2021-2030) ($MN)
Table 60 Europe Chronic Disease Management Market Outlook, By Asthma (2021-2030) ($MN)
Table 61 Europe Chronic Disease Management Market Outlook, By Chronic Obstructive Pulmonary Disorders (2021-2030) ($MN)
Table 62 Europe Chronic Disease Management Market Outlook, By Other Disease Types (2021-2030) ($MN)
Table 63 Europe Chronic Disease Management Market Outlook, By End User (2021-2030) ($MN)
Table 64 Europe Chronic Disease Management Market Outlook, By Healthcare Providers (2021-2030) ($MN)
Table 65 Europe Chronic Disease Management Market Outlook, By Healthcare Payers (2021-2030) ($MN)
Table 66 Europe Chronic Disease Management Market Outlook, By Other End Users (2021-2030) ($MN)
Table 67 Asia Pacific Chronic Disease Management Market Outlook, By Country (2021-2030) ($MN)
Table 68 Asia Pacific Chronic Disease Management Market Outlook, By Type (2021-2030) ($MN)
Table 69 Asia Pacific Chronic Disease Management Market Outlook, By Solutions (2021-2030) ($MN)
Table 70 Asia Pacific Chronic Disease Management Market Outlook, By On-Premise Solution (2021-2030) ($MN)
Table 71 Asia Pacific Chronic Disease Management Market Outlook, By Cloud-Based Solution (2021-2030) ($MN)
Table 72 Asia Pacific Chronic Disease Management Market Outlook, By Web-Based (2021-2030) ($MN)
Table 73 Asia Pacific Chronic Disease Management Market Outlook, By Services (2021-2030) ($MN)
Table 74 Asia Pacific Chronic Disease Management Market Outlook, By Consulting Services (2021-2030) ($MN)
Table 75 Asia Pacific Chronic Disease Management Market Outlook, By Implementation Services (2021-2030) ($MN)
Table 76 Asia Pacific Chronic Disease Management Market Outlook, By Educational Services (2021-2030) ($MN)
Table 77 Asia Pacific Chronic Disease Management Market Outlook, By Other Types (2021-2030) ($MN)
Table 78 Asia Pacific Chronic Disease Management Market Outlook, By Disease Type (2021-2030) ($MN)
Table 79 Asia Pacific Chronic Disease Management Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
Table 80 Asia Pacific Chronic Disease Management Market Outlook, By Diabetes (2021-2030) ($MN)
Table 81 Asia Pacific Chronic Disease Management Market Outlook, By Cancer (2021-2030) ($MN)
Table 82 Asia Pacific Chronic Disease Management Market Outlook, By Asthma (2021-2030) ($MN)
Table 83 Asia Pacific Chronic Disease Management Market Outlook, By Chronic Obstructive Pulmonary Disorders (2021-2030) ($MN)
Table 84 Asia Pacific Chronic Disease Management Market Outlook, By Other Disease Types (2021-2030) ($MN)
Table 85 Asia Pacific Chronic Disease Management Market Outlook, By End User (2021-2030) ($MN)
Table 86 Asia Pacific Chronic Disease Management Market Outlook, By Healthcare Providers (2021-2030) ($MN)
Table 87 Asia Pacific Chronic Disease Management Market Outlook, By Healthcare Payers (2021-2030) ($MN)
Table 88 Asia Pacific Chronic Disease Management Market Outlook, By Other End Users (2021-2030) ($MN)
Table 89 South America Chronic Disease Management Market Outlook, By Country (2021-2030) ($MN)
Table 90 South America Chronic Disease Management Market Outlook, By Type (2021-2030) ($MN)
Table 91 South America Chronic Disease Management Market Outlook, By Solutions (2021-2030) ($MN)
Table 92 South America Chronic Disease Management Market Outlook, By On-Premise Solution (2021-2030) ($MN)
Table 93 South America Chronic Disease Management Market Outlook, By Cloud-Based Solution (2021-2030) ($MN)
Table 94 South America Chronic Disease Management Market Outlook, By Web-Based (2021-2030) ($MN)
Table 95 South America Chronic Disease Management Market Outlook, By Services (2021-2030) ($MN)
Table 96 South America Chronic Disease Management Market Outlook, By Consulting Services (2021-2030) ($MN)
Table 97 South America Chronic Disease Management Market Outlook, By Implementation Services (2021-2030) ($MN)
Table 98 South America Chronic Disease Management Market Outlook, By Educational Services (2021-2030) ($MN)
Table 99 South America Chronic Disease Management Market Outlook, By Other Types (2021-2030) ($MN)
Table 100 South America Chronic Disease Management Market Outlook, By Disease Type (2021-2030) ($MN)
Table 101 South America Chronic Disease Management Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
Table 102 South America Chronic Disease Management Market Outlook, By Diabetes (2021-2030) ($MN)
Table 103 South America Chronic Disease Management Market Outlook, By Cancer (2021-2030) ($MN)
Table 104 South America Chronic Disease Management Market Outlook, By Asthma (2021-2030) ($MN)
Table 105 South America Chronic Disease Management Market Outlook, By Chronic Obstructive Pulmonary Disorders (2021-2030) ($MN)
Table 106 South America Chronic Disease Management Market Outlook, By Other Disease Types (2021-2030) ($MN)
Table 107 South America Chronic Disease Management Market Outlook, By End User (2021-2030) ($MN)
Table 108 South America Chronic Disease Management Market Outlook, By Healthcare Providers (2021-2030) ($MN)
Table 112 South America Chronic Disease Management Market Outlook, By Healthcare Payers (2021-2030) ($MN)
Table 113 South America Chronic Disease Management Market Outlook, By Other End Users (2021-2030) ($MN)
Table 114 Middle East & Africa Chronic Disease Management Market Outlook, By Country (2021-2030) ($MN)
Table 115 Middle East & Africa Chronic Disease Management Market Outlook, By Type (2021-2030) ($MN)
Table 116 Middle East & Africa Chronic Disease Management Market Outlook, By Solutions (2021-2030) ($MN)
Table 117 Middle East & Africa Chronic Disease Management Market Outlook, By On-Premise Solution (2021-2030) ($MN)
Table 118 Middle East & Africa Chronic Disease Management Market Outlook, By Cloud-Based Solution (2021-2030) ($MN)
Table 119 Middle East & Africa Chronic Disease Management Market Outlook, By Web-Based (2021-2030) ($MN)
Table 120 Middle East & Africa Chronic Disease Management Market Outlook, By Services (2021-2030) ($MN)
Table 121 Middle East & Africa Chronic Disease Management Market Outlook, By Consulting Services (2021-2030) ($MN)
Table 122 Middle East & Africa Chronic Disease Management Market Outlook, By Implementation Services (2021-2030) ($MN)
Table 123 Middle East & Africa Chronic Disease Management Market Outlook, By Educational Services (2021-2030) ($MN)
Table 124 Middle East & Africa Chronic Disease Management Market Outlook, By Other Types (2021-2030) ($MN)
Table 125 Middle East & Africa Chronic Disease Management Market Outlook, By Disease Type (2021-2030) ($MN)
Table 126 Middle East & Africa Chronic Disease Management Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
Table 127 Middle East & Africa Chronic Disease Management Market Outlook, By Diabetes (2021-2030) ($MN)
Table 128 Middle East & Africa Chronic Disease Management Market Outlook, By Cancer (2021-2030) ($MN)
Table 129 Middle East & Africa Chronic Disease Management Market Outlook, By Asthma (2021-2030) ($MN)
Table 130 Middle East & Africa Chronic Disease Management Market Outlook, By Chronic Obstructive Pulmonary Disorders (2021-2030) ($MN)
Table 131 Middle East & Africa Chronic Disease Management Market Outlook, By Other Disease Types (2021-2030) ($MN)
Table 132 Middle East & Africa Chronic Disease Management Market Outlook, By End User (2021-2030) ($MN)
Table 133 Middle East & Africa Chronic Disease Management Market Outlook, By Healthcare Providers (2021-2030) ($MN)
Table 134 Middle East & Africa Chronic Disease Management Market Outlook, By Healthcare Payers (2021-2030) ($MN)
Table 135 Middle East & Africa Chronic Disease Management Market Outlook, By Other End Users (2021-2030) ($MN)

Product Code: SMRC24254

According to Stratistics MRC, the Global Chronic Disease Management Market is accounted for $6.3 billion in 2023 and is expected to reach $15.6 billion by 2030 growing at a CAGR of 13.8% during the forecast period. The Chronic Disease Management Market is the healthcare sector dedicated to addressing long-term, non-communicable health conditions such as diabetes, heart disease, and cancer. It involves a range of strategies and technologies aimed at preventing, monitoring, and treating these conditions to improve patients' quality of life. Its uses include remote patient monitoring, personalized treatment plans, and data-driven interventions.

According to NCBI, chronic diseases account for about 60% of deaths and 43% of the global disease burden.

Market Dynamics:

Driver:

Increasing of aging population

As demographics shift towards an older populace, there is a heightened prevalence of chronic diseases, as many of these conditions become more common with age. This demographic trend places a substantial burden on healthcare systems and resources, necessitating enhanced disease management strategies. The demand for specialized care, preventive measures, and long-term support for chronic illnesses is on the rise, fostering the development of tailored healthcare solutions and technologies. Addressing the healthcare needs of the aging population not only improves their quality of life but also drives the growth of the chronic disease management market as it becomes increasingly essential in providing effective and efficient care.

Restraint:

Implementations of advanced programs are expensive

Developing and deploying cutting-edge technologies, remote monitoring systems, and personalized treatment solutions often require substantial financial investments. Healthcare organizations and providers may be constrained by budget limitations and face challenges in allocating resources for the adoption of expensive technologies. Additionally, these costs can translate to higher expenses for patients, limiting their access to advanced chronic disease management. The financial burden may also deter smaller healthcare facilities and underserved regions from offering comprehensive disease management services, potentially exacerbating health disparities. Mitigating these cost barriers is essential to ensure equitable access to effective chronic disease management solutions.

Opportunity:

Government healthcare policies and incentives

Many governments worldwide are recognizing the economic and public health implications of rising chronic disease burdens. As a result, they are implementing policies that encourage the development and adoption of innovative disease management solutions. Incentives may include financial support, reimbursement programs, and regulatory frameworks that promote the integration of technology and telehealth into healthcare systems, making it easier for providers to offer effective chronic disease management services. These policies not only stimulate market growth but also contribute to better access to care, reduced healthcare costs, and improved patient outcomes, creating a win-win scenario for healthcare stakeholders and patients alike.

Threat:

Stringent regulations and compliance requirements

While regulations are essential for ensuring patient safety and data security, an overly complex and restrictive regulatory environment can impede innovation and hinder the rapid development and deployment of new technologies and solutions for managing chronic diseases. Compliance challenges can increase the time and cost of bringing products to market, creating barriers for businesses and healthcare providers. Additionally, navigating a complex regulatory landscape may deter some companies from entering the market, limiting competition and potentially limiting the availability of advanced chronic disease management solutions, ultimately impacting patient care and healthcare system efficiency.

COVID-19 Impact:

The COVID-19 pandemic has had a profound impact on the Chronic Disease Management Market. With healthcare systems focused on responding to the pandemic, there has been a disruption in routine chronic disease care. Telemedicine and remote monitoring solutions gained prominence to minimize in-person visits and reduce exposure risks for vulnerable populations. However, the diversion of resources towards pandemic-related efforts and delays in routine screenings and treatments has led to a potential increase in unmanaged chronic conditions, which may have long-term health implications. The pandemic has accelerated the adoption of digital health solutions while highlighting the need for resilient and adaptable chronic disease management strategies.

The services segment is expected to be the largest during the forecast period

The services segment is expected to have lucrative growth in the market. Services in the market encompass a wide range of healthcare offerings tailored to address the needs of individuals dealing with long-term health conditions. These services include disease prevention and education, diagnostic testing, treatment planning, medication management, and lifestyle counseling. Healthcare providers offer patient-centered care by leveraging technology for remote monitoring, telehealth consultations, and data-driven interventions to track and manage chronic diseases effectively. Support groups and mental health services also play a vital role in addressing the emotional and psychological aspects of living with a chronic condition.

The diabetes segment is expected to have the highest CAGR during the forecast period

The diabetes segment is anticipated to witness the fastest CAGR growth during the forecast period. Diabetes is a central focus in the chronic disease, given its widespread prevalence and the need for comprehensive management. This chronic condition, characterized by high blood sugar levels, requires ongoing monitoring, lifestyle adjustments, and often medication or insulin therapy. Healthcare providers and digital health solutions offer a range of services, including glucose monitoring devices, diabetic education programs, personalized dietary and exercise plans, and telehealth consultations. The goal is to empower individuals with diabetes to better manage their condition, reduce the risk of complications, and improve their overall quality of life.

Region with largest share:

During the forecast period, it is expected that the North American market will continue to hold a majority of the market share. The region encompasses the United States and Canada, where the aging population, lifestyle-related diseases, and the rising burden of chronic illnesses drive the demand for innovative disease management solutions. The adoption of telehealth, wearable devices, and electronic health records is widespread, enabling remote monitoring and personalized care. Additionally, government policies and healthcare regulations in North America often encourage the development and implementation of chronic disease management programs, making it a fertile ground for healthcare innovation, with a focus on improving patient outcomes and reducing the economic impact of chronic diseases.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period. The region's significant population, rising middle class and lifestyle changes have led to an increasing prevalence of chronic diseases like diabetes, cardiovascular conditions, and respiratory disorders. Healthcare providers and technology companies are actively introducing innovative solutions for disease prevention, monitoring, and treatment. Telehealth services, mobile health apps, and remote monitoring devices are gaining traction, especially in countries like China and India. Government initiatives to improve healthcare access and the growing awareness among patients about the importance of managing chronic conditions contribute to the market's expansion.

Key players in the market

Some of the key players in Chronic Disease Management market include: HealthSmart Holdings, Inc., Vivify Health, Inc, Medecision, Inc., Pegasystems Inc., Allscripts Healthcare Solutions, Inc., Altruista Health, AxisPoint Health, Epic Corporation Inc., TriZetto Corporation, EXL Healthcare, ZeOmega Inc. and Health Catalyst.

Key Developments:

In January 2023, MedStar Health and Zephyr AI, Inc. a start-up specializing in precision medicine technology announced their partnership to work to improve outcomes for chronic diseases, beginning with type 2 diabetes (T2D).

In October 2022, Enli Health Intelligence, a supplier of digital solutions for population health management, was acquired by Cedar Gate Technologies. With the addition of cohort, population, and patient management technologies, risk & quality indicators, gaps in care identification, and patient outreach opportunities, Cedar Gate's enterprise value-based care platform was intended to be expanded for improved outcomes and long-term financial viability.

Types Covered:

Solutions
Services
Other Types

Disease Types Covered:

Cardiovascular Diseases
Diabetes
Cancer
Asthma
Chronic Obstructive Pulmonary Disorders
Other Disease Types

End Users Covered:

Healthcare Providers
Healthcare Payers
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Chronic Disease Management Market, By Type

5.1 Introduction
5.2 Solutions
- 5.2.1 On-Premise Solution
- 5.2.2 Cloud-Based Solution
- 5.2.3 Web-Based
5.3 Services
- 5.3.1 Consulting Services
- 5.3.2 Implementation Services
- 5.3.3 Educational Services
5.4 Other Types

6 Global Chronic Disease Management Market, By Disease Type

6.1 Introduction
6.2 Cardiovascular Diseases
6.3 Diabetes
6.4 Cancer
6.5 Asthma
6.6 Chronic Obstructive Pulmonary Disorders
6.7 Other Disease Types

7 Global Chronic Disease Management Market, By End User

7.1 Introduction
7.2 Healthcare Providers
7.3 Healthcare Payers
7.4 Other End Users

8 Global Chronic Disease Management Market, By Geography

8.1 Introduction
8.2 North America
- 8.2.1 US
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 Italy
- 8.3.4 France
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 New Zealand
- 8.4.6 South Korea
- 8.4.7 Rest of Asia Pacific
8.5 South America
- 8.5.1 Argentina
- 8.5.2 Brazil
- 8.5.3 Chile
- 8.5.4 Rest of South America
8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 Qatar
- 8.6.4 South Africa
- 8.6.5 Rest of Middle East & Africa

9 Key Developments

9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling

10.1 HealthSmart Holdings, Inc.
10.2 Vivify Health, Inc
10.3 Medecision, Inc.
10.4 Pegasystems Inc.
10.5 Allscripts Healthcare Solutions, Inc.
10.6 Altruista Health
10.7 AxisPoint Health
10.8 Epic Corporation Inc.
10.9 TriZetto Corporation
10.10 EXL Healthcare
10.11 ZeOmega Inc.
10.12 Health Catalyst